Schroder Global Healthcare Fund Z Income GBP |
Performance History | 28/02/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 13.5 | -1.5 | 1.5 | 3.5 | 4.1 |
![]() | +/-Cat | 4.1 | 3.1 | 4.6 | 2.5 | -0.5 |
![]() | +/-B’mrk | -4.7 | -7.4 | 4.0 | 0.8 | -2.6 |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 14/03/2025 | GBP 2.46 | |
Day Change | -0.20% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | Global | |
ISIN | GB00B76V7R15 | |
Fund Size (Mil) 14/03/2025 | GBP 399.03 | |
Share Class Size (Mil) 14/03/2025 | GBP 36.28 | |
Max Initial Charge | - | |
Ongoing Charge 05/02/2025 | 0.92% |
Investment Objective: Schroder Global Healthcare Fund Z Income GBP |
The Fund aims to provide capital growth by investing in equity and equity related securities of healthcare and medical related companies worldwide. The Fund is actively managed and invests at least 80% of its assets in equity and equity related securities of companies worldwide, which are engaged in healthcare provision, medical services and related products. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Bowler 31/03/2004 | ||
Inception Date 08/11/2011 |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Portfolio Profile for Schroder Global Healthcare Fund Z Income GBP | 30/11/2024 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 6.18 |
![]() | ![]() | 5.16 |
![]() | ![]() | 5.06 |
![]() | ![]() | 3.72 |
![]() | ![]() | 3.45 |
![]() | ||
![]() ![]() ![]() | ||
Schroder Global Healthcare Fund Z Income GBP |
Growth Of 1000 (GBP) | 28/02/2025 |
|
Annual Returns (GBP) | 28/02/2025 | |||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 28/02 | |
Price Return | 7.66 | 22.26 | 22.90 | 13.49 | -1.55 | 1.50 | 3.46 | 4.13 |
+/- Category | 4.97 | 5.24 | 5.43 | 4.05 | 3.12 | 4.62 | 2.49 | -0.46 |
+/- Category Index | - | - | - | -4.73 | -7.35 | 4.03 | 0.76 | -2.64 |
% Rank in Category | 28 | 19 | 24 | 47 | 47 | 21 | 33 | 62 |
Trailing Returns (GBP) | 14/03/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.20 | -1.23 | -1.16 |
1 Week | -2.88 | -0.38 | -0.09 |
1 Month | -5.68 | -1.06 | -3.62 |
3 Months | -2.23 | 0.13 | -2.55 |
6 Months | -9.46 | -4.00 | -3.16 |
YTD | -0.49 | -0.60 | -2.50 |
1 Year | -5.71 | -2.32 | -4.29 |
3 Years Annualised | 4.24 | 2.49 | -0.44 |
5 Years Annualised | 9.07 | 2.02 | 0.31 |
10 Years Annualised | 8.62 | 2.20 | 0.51 |
Category: Sector Equity Healthcare | |||
Category Index: Morningstar Gbl Health TME NR USD |
Quarterly Returns (GBP) | 28/02/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 11.62 | 0.49 | -3.32 | -4.59 |
2023 | -2.07 | 3.07 | 0.10 | 0.46 |
2022 | -1.66 | -2.71 | 3.04 | -0.13 |
2021 | -0.24 | 8.74 | 1.13 | 3.44 |
2020 | -3.70 | 17.17 | 4.15 | 4.58 |
Morningstar Rating™(Relative to Category) | 28/02/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
Category : Sector Equity Healthcare | Click here to see our Methodology |
Volatility Measurements | 28/02/2025 | ||||||||||
| |||||||||||
Modern Portfolio Statistics | 28/02/2025 | 28/02/2025 |
Standard Index | Best Fit Index | |
Morningstar Gbl Health TME NR USD | Morningstar Gbl Health TME NR USD | |
3-Yr Beta | 0.91 | 0.91 |
3-Yr Alpha | -0.44 | -0.44 |
Investment Style Details | 30/11/2024 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Category: Sector Equity Healthcare |
Asset Allocation | 30/11/2024 |
|
World Regions | 30/11/2024 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Category: Sector Equity Healthcare |
Sector Weightings | 30/11/2024 | ||||||
| |||||||
Category: Sector Equity Healthcare |
Top 10 Holdings | 30/11/2024 |
Portfolio NEW | |
Total Number of Equity Holdings | 64 |
Total Number of Bond Holdings | 0 |
Assets in Top 10 Holdings | 38.86 |
Name | Sector | Country | % of Assets | ||
![]() | ![]() | United States | 6.18 | ||
![]() | ![]() | Switzerland | 5.16 | ||
![]() | ![]() | United States | 5.06 | ||
![]() | ![]() | United States | 3.72 | ||
![]() | ![]() | United Kingdom | 3.45 | ||
![]() | ![]() | Denmark | 3.28 | ||
![]() | ![]() | United States | 3.12 | ||
![]() | ![]() | United States | 2.98 | ||
![]() | ![]() | United States | 2.98 | ||
![]() | ![]() | United States | 2.92 | ||
![]() ![]() ![]() | |||||
Category: Sector Equity Healthcare | |||||
Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
![]() | |
Biography | |
John Bowler is a Fund Manager and Global Sector Specialist at Schroders, which involves covering the healthcare sector and manager of the Schroder Global Healthcare Fund, as well as having primary research responsibility for Pan-European pharmaceuticals. He joined Schroders in 2003 and is based in London. Qualifications: BA in Biology from the University of Manchester. |
Fees and Expenses | ||||||||||||
|
Purchase Details | ||||||||
| ||||||||
|